The evolution of firm growth dynamics in the US pharmaceutical industry
The evolution of firm growth dynamics in the US pharmaceutical industry
The evolution of firm growth dynamics in the US pharmaceutical industry, Regional Studies. This paper studies the dynamics of firm growth and firm size distribution in the pharmaceutical industry from 1950 to 2003. Growth dynamics are studied in the context of how the size composition of firms changes, how innovation patterns change, and how location leads to growth differentials among US firms. It is found that the growth advantage of small pharmaceutical firms increases after the 1980s as small firms become more active in patenting and their patenting activities become more ‘persistent’. Location is found to affect growth differences only for the most innovative firms (that is, for non-innovative firms, location does not matter).
firm growth, innovation, pharmaceutical industry, L100, L110, croissance des entreprises, industrie pharmaceutique, firmenwachstum, pharmaindustrie, crecimiento de empresas, innovación, industria farmacéutica
1053-1066
Demirel, Pelin
687c839d-b7dc-4914-972a-293ab9f014c2
Mazzucato, Mariana
57ce93e5-6a6e-43eb-98d6-2e59ac09f100
21 January 2010
Demirel, Pelin
687c839d-b7dc-4914-972a-293ab9f014c2
Mazzucato, Mariana
57ce93e5-6a6e-43eb-98d6-2e59ac09f100
Demirel, Pelin and Mazzucato, Mariana
(2010)
The evolution of firm growth dynamics in the US pharmaceutical industry.
Regional Studies, 44 (8), .
(doi:10.1080/00343400903241469).
Abstract
The evolution of firm growth dynamics in the US pharmaceutical industry, Regional Studies. This paper studies the dynamics of firm growth and firm size distribution in the pharmaceutical industry from 1950 to 2003. Growth dynamics are studied in the context of how the size composition of firms changes, how innovation patterns change, and how location leads to growth differentials among US firms. It is found that the growth advantage of small pharmaceutical firms increases after the 1980s as small firms become more active in patenting and their patenting activities become more ‘persistent’. Location is found to affect growth differences only for the most innovative firms (that is, for non-innovative firms, location does not matter).
Text
Demirel_Mazzucato_2010_final_paper.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: 21 January 2010
Keywords:
firm growth, innovation, pharmaceutical industry, L100, L110, croissance des entreprises, industrie pharmaceutique, firmenwachstum, pharmaindustrie, crecimiento de empresas, innovación, industria farmacéutica
Organisations:
Centre for Innovation & Enterprise
Identifiers
Local EPrints ID: 377727
URI: http://eprints.soton.ac.uk/id/eprint/377727
ISSN: 0034-3404
PURE UUID: 2817aea6-1bb7-4db8-8ac9-70b65ca1c3e4
Catalogue record
Date deposited: 10 Jun 2015 15:21
Last modified: 14 Mar 2024 20:08
Export record
Altmetrics
Contributors
Author:
Pelin Demirel
Author:
Mariana Mazzucato
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics